المؤلفون: Desport, Jean-Claude, Preux, Pierre-Marie, Truong, CT, Vallat, Jean-Michel, Laokpessi, A, Couratier, Philippe

المساهمون: Grelier, Elisabeth, Neuroépidémiologie Tropicale et Comparée (NETEC), Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Université de Limoges (UNILIM), Service d'Hépato-Gastro-Entérologie et Nutrition [CHU Limoges], CHU Limoges, Laboratoire de Biostatistique et d'Informatique Médicale, Université de Limoges (UNILIM), Service de l'Information Médicale et de l'Évaluation [CHU Limoges] (SIME), Service de Neurologie [CHU Limoges], Centre de référence national neuropathies périphériques rares [CHU Limoges]

المصدر: Communication orale présentée au "10th International Symposium on ALS/MND"
Communication orale présentée au "10th International Symposium on ALS/MND", Nov 1999, Vancouver, Canada

مصطلحات موضوعية: [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, ComputingMilieux_MISCELLANEOUS

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::47628b23eafe4266f994f84ad6a5e15d
https://hal-unilim.archives-ouvertes.fr/hal-01128703

المؤلفون: Desport, Jean-Claude, Preux, Pierre-Marie, Truong, CT, Vallat, Jean-Michel, Sautereau, D, Couratier, Philippe

المساهمون: Grelier, Elisabeth, Neuroépidémiologie Tropicale et Comparée (NETEC), Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Université de Limoges (UNILIM), Service d'Hépato-Gastro-Entérologie et Nutrition [CHU Limoges], CHU Limoges, Service de Neurologie [CHU Limoges], Service de l'Information Médicale et de l'Évaluation [CHU Limoges] (SIME), Laboratoire de Biostatistique et d'Informatique Médicale, Université de Limoges (UNILIM), Centre de référence national neuropathies périphériques rares [CHU Limoges]

المصدر: Communication orale présentée au "9th International Symposium on ALS/MND"
Communication orale présentée au "9th International Symposium on ALS/MND", Nov 1998, Munich, Germany. pp.50

مصطلحات موضوعية: [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, ComputingMilieux_MISCELLANEOUS

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::22b9399fead2f7f07716da55da1368f6
https://hal-unilim.archives-ouvertes.fr/hal-01123816

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Desport, Jc, Pierre-Marie Preux, Truong, Ct, Courat, L., Vallat, Jm, Couratier, P.

المصدر: Scopus-Elsevier
ResearcherID

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3390719e37546607c3b74cd103bcc856
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034157557&partnerID=MN8TOARS

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: La MT; College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea., Hoang VH; Faculty of Pharmacy & PHENIKAA Institute for Advanced Study (PIAS), PHENIKAA University, Hanoi, 12116, Viet Nam., Sahu R; College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea., Nguyen CT; Faculty of Pharmaceutical Chemistry and Technology, Hanoi University of Pharmacy, Hanoi, 10000, Viet Nam., Nam G; School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, 16419, Republic of Korea., Park HJ; School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, 16419, Republic of Korea., Park M; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul, 152-703, Republic of Korea; Department of Biomedical Research Center, Korea University Guro Hospital, Korea University, Seoul, 152-703, Republic of Korea; Brain Korea 21 Program for Biomedical Science, Korea University College of Medicine, Korea University, Seoul, 152-703, Republic of Korea., Kim YJ; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul, 152-703, Republic of Korea; Department of Biomedical Research Center, Korea University Guro Hospital, Korea University, Seoul, 152-703, Republic of Korea; Brain Korea 21 Program for Biomedical Science, Korea University College of Medicine, Korea University, Seoul, 152-703, Republic of Korea., Kim JY; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul, 152-703, Republic of Korea; Department of Biomedical Research Center, Korea University Guro Hospital, Korea University, Seoul, 152-703, Republic of Korea., Ann J; College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea., Seo JH; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul, 152-703, Republic of Korea; Department of Biomedical Research Center, Korea University Guro Hospital, Korea University, Seoul, 152-703, Republic of Korea; Brain Korea 21 Program for Biomedical Science, Korea University College of Medicine, Korea University, Seoul, 152-703, Republic of Korea., Lee J; College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea. Electronic address: jeewoo@snu.ac.kr.

المصدر: European journal of medicinal chemistry [Eur J Med Chem] 2024 Oct 05; Vol. 276, pp. 116620. Date of Electronic Publication: 2024 Jun 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: HSP90 Heat-Shock Proteins*/antagonists & inhibitors , HSP90 Heat-Shock Proteins*/metabolism , Indazoles*/pharmacology , Indazoles*/chemistry , Indazoles*/chemical synthesis , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemistry , Antineoplastic Agents*/chemical synthesis , Drug Screening Assays, Antitumor* , Molecular Docking Simulation* , Cell Proliferation*/drug effects, Humans ; Structure-Activity Relationship ; Animals ; Molecular Structure ; Drug Discovery ; Dose-Response Relationship, Drug ; Cell Line, Tumor ; Female ; Breast Neoplasms/drug therapy ; Breast Neoplasms/pathology ; Breast Neoplasms/metabolism

المؤلفون: Park M; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea.; Brain Korea 21 Program for Biomedical Science, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea., Jung E; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea.; Department of Biomedical Research Center, Korea University Guro Hospital, Korea University, Seoul 08308, Republic of Korea., Park JM; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea.; Brain Korea 21 Program for Biomedical Science, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea., Park S; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea.; Brain Korea 21 Program for Biomedical Science, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea., Ko D; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea.; Brain Korea 21 Program for Biomedical Science, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea., Seo J; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea.; Brain Korea 21 Program for Biomedical Science, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea., Kim S; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea.; Brain Korea 21 Program for Biomedical Science, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea., Nam KD; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea.; Department of Biomedical Research Center, Korea University Guro Hospital, Korea University, Seoul 08308, Republic of Korea., Kang YK; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea.; Department of Biomedical Research Center, Korea University Guro Hospital, Korea University, Seoul 08308, Republic of Korea., Farrand L; Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, South Australia 5000, Australia., Hoang VH; Faculty of Pharmacy, PHENIKAA University, Hanoi 12116, Vietnam., Nguyen CT; Department of Organic Chemistry, Hanoi University of Pharmacy, Hanoi 10000, Vietnam., La MT; Laboratory of Medicinal Chemistry, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea., Nam G; School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do 16419, Republic of Korea., Park HJ; School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do 16419, Republic of Korea., Ann J; Laboratory of Medicinal Chemistry, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea., Lee J; Laboratory of Medicinal Chemistry, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea., Kim YJ; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea.; Brain Korea 21 Program for Biomedical Science, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea.; Department of Biomedical Research Center, Korea University Guro Hospital, Korea University, Seoul 08308, Republic of Korea., Kim JY; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea.; Department of Biomedical Research Center, Korea University Guro Hospital, Korea University, Seoul 08308, Republic of Korea., Seo JH; Division of Medical Oncology, Department of Internal Medicine, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea.; Brain Korea 21 Program for Biomedical Science, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea.; Department of Biomedical Research Center, Korea University Guro Hospital, Korea University, Seoul 08308, Republic of Korea.

المصدر: Theranostics [Theranostics] 2024 Mar 31; Vol. 14 (6), pp. 2442-2463. Date of Electronic Publication: 2024 Mar 31 (Print Publication: 2024).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101552395 Publication Model: eCollection Cited Medium: Internet ISSN: 1838-7640 (Electronic) Linking ISSN: 18387640 NLM ISO Abbreviation: Theranostics Subsets: MEDLINE

مواضيع طبية MeSH: HSP90 Heat-Shock Proteins*/antagonists & inhibitors , HSP90 Heat-Shock Proteins*/metabolism , Drug Resistance, Neoplasm*/drug effects , Breast Neoplasms*/drug therapy , Breast Neoplasms*/metabolism , Breast Neoplasms*/pathology , Trastuzumab*/pharmacology , Trastuzumab*/therapeutic use , Receptor, ErbB-2*/metabolism , Receptor, ErbB-2*/antagonists & inhibitors , Xenograft Model Antitumor Assays*, Humans ; Animals ; Female ; Cell Line, Tumor ; Mice ; Neoplastic Stem Cells/drug effects ; Neoplastic Stem Cells/metabolism ; Mice, Nude ; Apoptosis/drug effects ; Cell Survival/drug effects ; Antineoplastic Agents/pharmacology